Pediatric Atopic Dermatitis (AD) Internet Survey
Not Applicable
Withdrawn
- Conditions
- Atopic Dermatitis
- Interventions
- Behavioral: Weekly Internet survey
- Registration Number
- NCT01385527
- Lead Sponsor
- Wake Forest University
- Brief Summary
The purpose of this study is to evaluate whether participation in an Internet-based intervention helps improve atopic dermatitis treatment outcomes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Any child age 2 to 8 with a diagnosis of atopic dermatitis confirmed by a dermatologist, together with the child's parent/guardian. Written consent must be given by parent/guardian.
Exclusion Criteria
- Child is less than 2 or greater than 8 years of age.
- Known allergy or sensitivity to topical triamcinolone in the child.
- Inability to complete all study-related visits, or inability to complete the Internet survey due to inadequate Internet access.
- Introduction of any other prescription medication, topical or systemic, for atopic dermatitis while participating in the study. Subjects who are on systemic anti-inflammatory treatments for atopic dermatitis must be on a stable dose for at least 3 months prior to enrollment.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Weekly Internet survey w medication Weekly Internet survey Weekly survey via email plus topical triamcinolone Weekly Internet survey w medication Topical Triamcinolone Weekly survey via email plus topical triamcinolone Topical triamcinolone only Topical Triamcinolone Standard of care
- Primary Outcome Measures
Name Time Method Adherence to topical triamcinolone 12 weeks
- Secondary Outcome Measures
Name Time Method Eczema Area Severity Index 12 weeks Investigator's Global Assessment 12 weeks